Javascript must be enabled to continue!
THE SEROPOSITIVITY OF PARVOVIRUS B19 AMONG KIDNEY TRANSPLANT RECIPIENTS
View through CrossRef
Background: Parvovirus B19 (PV-B19) is a single strand DNA virus that is responsible for causing several diseases in humans. Parvovirus B19 induced persistent anemia or/and pancytopenia or/and reticulocyteopenia in renal transplant recipients (RTRs).
Objective: To find out any association between PV-B19 reactivation / primary infections with abnormal renal function tests, and post-transplantation period in renal transplant patients.
Methods: A quality enzyme linked immunosorbent assay technique was applied for detection of anti-human PV-B19 IgM (DRG-Germany) and IgG (DRG- Germany) in sera of 50 renal transplant recipients followed up for three successive months and 50 normal were collected from the Center of Kidney Diseases and Transplantation in the Medical City of Baghdad and Al-Khayal Hospital and other many private laboratories, Iraq, during the period from August 2015 till February 2016. The age was ranged from 11-57 years.
Results: This prospective study included fifty renal transplant recipients with fifty subjects as a control group. The mean ± standard deviation of ages for RTRs was 32.90 ±12.76, which was comparable to that of healthy controls mean 34.02 ± 14.23 ranging for both RTRs and control group between 11-57 years old. Thirty five (70%) RTR aged less than 40 years, and the remaining fifteen (30%) were above 40 years old, and 38/50 (76%) of these RTRs were males. Seropositivity rate in control was 2/50 (4%) but seropositivity rate in patients was 10% (5 cases) and 10% (5 cases) as turning positive for an individual occurrence of human PV-B19 IgM alone at P value = 0.0299 and 9/50 (18%) from control positive for IgG, while 60% (30 cases) for a similar individual rate of positive human parvovirus B19 IgG at P value < 0.0001.
Conclusion: The human PV-B19 infection rate was significantly higher among renal transplant recipients than normal controls. Infections correlated with abnormal renal functions tests, and which may in turn cause anemia and/or reticulocytopenia.
Keywords: Parvovirus-B19, anemia, reticulocytopenia, renal transplant recipients, ELISA
Citation: Zainab A. Hlail, Ahmed S. Abdulamir, Ali J.H. Al-Saedi. The seropositivity of Parvovirus B19 among kidney transplant recipients. Iraqi JMS. 2017; Vol. 15(1): 88-93. doi: 10.22578/IJMS.15.1.11
College of Medicine, Alnahrain University
Title: THE SEROPOSITIVITY OF PARVOVIRUS B19 AMONG KIDNEY TRANSPLANT RECIPIENTS
Description:
Background: Parvovirus B19 (PV-B19) is a single strand DNA virus that is responsible for causing several diseases in humans.
Parvovirus B19 induced persistent anemia or/and pancytopenia or/and reticulocyteopenia in renal transplant recipients (RTRs).
Objective: To find out any association between PV-B19 reactivation / primary infections with abnormal renal function tests, and post-transplantation period in renal transplant patients.
Methods: A quality enzyme linked immunosorbent assay technique was applied for detection of anti-human PV-B19 IgM (DRG-Germany) and IgG (DRG- Germany) in sera of 50 renal transplant recipients followed up for three successive months and 50 normal were collected from the Center of Kidney Diseases and Transplantation in the Medical City of Baghdad and Al-Khayal Hospital and other many private laboratories, Iraq, during the period from August 2015 till February 2016.
The age was ranged from 11-57 years.
Results: This prospective study included fifty renal transplant recipients with fifty subjects as a control group.
The mean ± standard deviation of ages for RTRs was 32.
90 ±12.
76, which was comparable to that of healthy controls mean 34.
02 ± 14.
23 ranging for both RTRs and control group between 11-57 years old.
Thirty five (70%) RTR aged less than 40 years, and the remaining fifteen (30%) were above 40 years old, and 38/50 (76%) of these RTRs were males.
Seropositivity rate in control was 2/50 (4%) but seropositivity rate in patients was 10% (5 cases) and 10% (5 cases) as turning positive for an individual occurrence of human PV-B19 IgM alone at P value = 0.
0299 and 9/50 (18%) from control positive for IgG, while 60% (30 cases) for a similar individual rate of positive human parvovirus B19 IgG at P value < 0.
0001.
Conclusion: The human PV-B19 infection rate was significantly higher among renal transplant recipients than normal controls.
Infections correlated with abnormal renal functions tests, and which may in turn cause anemia and/or reticulocytopenia.
Keywords: Parvovirus-B19, anemia, reticulocytopenia, renal transplant recipients, ELISA
Citation: Zainab A.
Hlail, Ahmed S.
Abdulamir, Ali J.
H.
Al-Saedi.
The seropositivity of Parvovirus B19 among kidney transplant recipients.
Iraqi JMS.
2017; Vol.
15(1): 88-93.
doi: 10.
22578/IJMS.
15.
1.
11.
Related Results
Seroprevalence of anti-Parvovirus B19 IgG in childbearing age women in Pleven region (Bulgaria)
Seroprevalence of anti-Parvovirus B19 IgG in childbearing age women in Pleven region (Bulgaria)
Abstract
Background
Parvovirus B19 is a widespread infection in childhood. Seroprevalence of anti-Parvovirus B19 increases with ...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Molecular and Phylogenetic Characterization of Parvovirus B19 Strains Detected in the Pediatric Population of the Greater Thessaloniki Region in Greece During March–April 2024
Molecular and Phylogenetic Characterization of Parvovirus B19 Strains Detected in the Pediatric Population of the Greater Thessaloniki Region in Greece During March–April 2024
Parvovirus B19 is a DNA virus. Most parvoviruses infect animals; Parvovirus B19 infects humans. Parvovirus B19 is mainly transmitted through respiratory droplets during close conta...
Prolonged Parvovirus B19 Viremia in Spite of Neutralizing Antibodies after Erythema Infectiosum in Pregnancy
Prolonged Parvovirus B19 Viremia in Spite of Neutralizing Antibodies after Erythema Infectiosum in Pregnancy
<i>Objective:</i> To check the clearance of parvovirus B19 in the course of the development of neutralizing antibodies after Erythema infectiosum in pregnancy. <i>...
Erythema Infectiosum: A Narrative Review
Erythema Infectiosum: A Narrative Review
Background:
Erythema infectiosum occurs worldwide. School-aged children are most often affected. Since the diagnosis is mainly clinical, physicians should be well-versed in the cli...
A study on the relationship between anemia and human parvovirus B19 viremia in dialysis patients
A study on the relationship between anemia and human parvovirus B19 viremia in dialysis patients
Introduction: Parvovirus B19 is recognized as a possible cause of
chronic anemia in patients with end- stage renal disease (ESRD)
undergoing hemodialysis. This can result from redu...
Chronic Fatigue Syndrome after Human Parvovirus B19 Infection without Persistent Viremia
Chronic Fatigue Syndrome after Human Parvovirus B19 Infection without Persistent Viremia
<i>Background:</i> It is unclear how often chronic fatigue syndrome (CFS) appears after human parvovirus B19 (B19) infection and whether prolonged B19 viremia or some o...
Association of Blood Indices Changes with Parvovirus B19 Infection inThalassemia Patients
Association of Blood Indices Changes with Parvovirus B19 Infection inThalassemia Patients
Parvovirus B19 is responsible for several clinical conditions, such as infectious erythematosus, joint inflammation, fetal hydrops, and chronic hemolytic anemia resembling thalasse...

